EMEA (Europe, Middle East and Africa) Eosinophilic Esophagitis Drug Market Report 2018

EMEA (Europe, Middle East and Africa) Eosinophilic Esophagitis Drug Market Report 2018

1 Eosinophilic Esophagitis Drug Overview

1.1 Product Overview and Scope of Eosinophilic Esophagitis Drug

1.2 Classification of Eosinophilic Esophagitis Drug

1.2.1 EMEA Eosinophilic Esophagitis Drug Market Size (Sales) Comparison by Type (2013-2025)

1.2.2 EMEA Eosinophilic Esophagitis Drug Market Size (Sales) Market Share by Type (Product Category) in 2017

1.2.3 RPC-4046

1.2.4 Budesonide

1.2.5 Qi-201

1.2.6 CALY-002

1.2.7 Others

1.3 EMEA Eosinophilic Esophagitis Drug Market by Application/End Users

1.3.1 EMEA Eosinophilic Esophagitis Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 EMEA Eosinophilic Esophagitis Drug Market by Region

1.4.1 EMEA Eosinophilic Esophagitis Drug Market Size (Value) Comparison by Region (2013-2025)

1.4.2 Europe Status and Prospect (2013-2025)

1.4.3 Middle East Status and Prospect (2013-2025)

1.4.4 Africa Status and Prospect (2013-2025)

1.5 EMEA Market Size (Value and Volume) of Eosinophilic Esophagitis Drug (2013-2025)

1.5.1 EMEA Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2025)

1.5.2 EMEA Eosinophilic Esophagitis Drug Revenue and Growth Rate (2013-2025)

2 EMEA Eosinophilic Esophagitis Drug Competition by Manufacturers/Players/Suppliers, Region, Type and Application

2.1 EMEA Eosinophilic Esophagitis Drug Market Competition by Players/Manufacturers

2.1.1 EMEA Eosinophilic Esophagitis Drug Sales Volume and Market Share of Major Players (2013-2018)

2.1.2 EMEA Eosinophilic Esophagitis Drug Revenue and Share by Players (2013-2018)

2.1.3 EMEA Eosinophilic Esophagitis Drug Sale Price by Players (2013-2018)

2.2 EMEA Eosinophilic Esophagitis Drug (Volume and Value) by Type/Product Category

2.2.1 EMEA Eosinophilic Esophagitis Drug Sales and Market Share by Type (2013-2018)

2.2.2 EMEA Eosinophilic Esophagitis Drug Revenue and Market Share by Type (2013-2018)

2.2.3 EMEA Eosinophilic Esophagitis Drug Sale Price by Type (2013-2018)

2.3 EMEA Eosinophilic Esophagitis Drug (Volume) by Application

2.4 EMEA Eosinophilic Esophagitis Drug (Volume and Value) by Region

2.4.1 EMEA Eosinophilic Esophagitis Drug Sales and Market Share by Region (2013-2018)

2.4.2 EMEA Eosinophilic Esophagitis Drug Revenue and Market Share by Region (2013-2018)

2.4.3 EMEA Eosinophilic Esophagitis Drug Sales Price by Region (2013-2018)

3 Europe Eosinophilic Esophagitis Drug (Volume, Value and Sales Price), by Players, Countries, Type and Application

3.1 Europe Eosinophilic Esophagitis Drug Sales and Value (2013-2018)

3.1.1 Europe Eosinophilic Esophagitis Drug Sales Volume and Growth Rate (2013-2018)

3.1.2 Europe Eosinophilic Esophagitis Drug Revenue and Growth Rate (2013-2018)

3.2 Europe Eosinophilic Esophagitis Drug Sales and Market Share by Type

3.3 Europe Eosinophilic Esophagitis Drug Sales and Market Share by Application

3.4 Europe Eosinophilic Esophagitis Drug Sales Volume and Value (Revenue) by Countries

3.4.1 Europe Eosinophilic Esophagitis Drug Sales Volume by Countries (2013-2018)

3.4.2 Europe Eosinophilic Esophagitis Drug Revenue by Countries (2013-2018)

3.4.3 Germany Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

3.4.4 France Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

3.4.5 UK Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

3.4.6 Russia Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

3.4.7 Italy Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

3.4.8 Benelux Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

4 Middle East Eosinophilic Esophagitis Drug (Volume, Value and Sales Price), by Region, Type and Application

4.1 Middle East Eosinophilic Esophagitis Drug Sales and Value (2013-2018)

4.1.1 Middle East Eosinophilic Esophagitis Drug Sales Volume and Growth Rate (2013-2018)

4.1.2 Middle East Eosinophilic Esophagitis Drug Revenue and Growth Rate (2013-2018)

4.2 Middle East Eosinophilic Esophagitis Drug Sales and Market Share by Type

4.3 Middle East Eosinophilic Esophagitis Drug Sales and Market Share by Application

4.4 Middle East Eosinophilic Esophagitis Drug Sales Volume and Value (Revenue) by Countries

4.4.1 Middle East Eosinophilic Esophagitis Drug Sales Volume by Countries (2013-2018)

4.4.2 Middle East Eosinophilic Esophagitis Drug Revenue by Countries (2013-2018)

4.4.3 Saudi Arabia Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

4.4.4 Israel Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

4.4.5 UAE Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

4.4.6 Iran Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

5 Africa Eosinophilic Esophagitis Drug (Volume, Value and Sales Price) by Players, Countries, Type and Application

5.1 Africa Eosinophilic Esophagitis Drug Sales and Value (2013-2018)

5.1.1 Africa Eosinophilic Esophagitis Drug Sales Volume and Growth Rate (2013-2018)

5.1.2 Africa Eosinophilic Esophagitis Drug Revenue and Growth Rate (2013-2018)

5.2 Africa Eosinophilic Esophagitis Drug Sales and Market Share by Type

5.3 Africa Eosinophilic Esophagitis Drug Sales and Market Share by Application

5.4 Africa Eosinophilic Esophagitis Drug Sales Volume and Value (Revenue) by Countries

5.4.1 Africa Eosinophilic Esophagitis Drug Sales Volume by Countries (2013-2018)

5.4.2 Africa Eosinophilic Esophagitis Drug Revenue by Countries (2013-2018)

5.4.3 South Africa Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

5.4.4 Nigeria Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

5.4.5 Egypt Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

5.4.6 Algeria Eosinophilic Esophagitis Drug Sales and Growth Rate (2013-2018)

6 EMEA Eosinophilic Esophagitis Drug Manufacturers/Players Profiles and Sales Data

6.1 Adare Pharmaceuticals Inc

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Eosinophilic Esophagitis Drug Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Adare Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.1.4 Main Business/Business Overview

6.2 Calypso Biotech SA

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Eosinophilic Esophagitis Drug Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Calypso Biotech SA Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.2.4 Main Business/Business Overview

6.3 Celgene Corp

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Eosinophilic Esophagitis Drug Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Celgene Corp Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.3.4 Main Business/Business Overview

6.4 DBV Technologies SA

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Eosinophilic Esophagitis Drug Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 DBV Technologies SA Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.4.4 Main Business/Business Overview

6.5 Dr. Falk Pharma GmbH

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Eosinophilic Esophagitis Drug Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Dr. Falk Pharma GmbH Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.5.4 Main Business/Business Overview

6.6 Quorum Innovations LLC

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Eosinophilic Esophagitis Drug Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Quorum Innovations LLC Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.6.4 Main Business/Business Overview

6.7 Regeneron Pharmaceuticals Inc

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Eosinophilic Esophagitis Drug Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Regeneron Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.7.4 Main Business/Business Overview

6.8 Shire Plc

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Eosinophilic Esophagitis Drug Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Shire Plc Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.8.4 Main Business/Business Overview

7 Eosinophilic Esophagitis Drug Manufacturing Cost Analysis

7.1 Eosinophilic Esophagitis Drug Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Eosinophilic Esophagitis Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Eosinophilic Esophagitis Drug Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Eosinophilic Esophagitis Drug Major Manufacturers in 2017

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 EMEA Eosinophilic Esophagitis Drug Market Forecast (2018-2025)

11.1 EMEA Eosinophilic Esophagitis Drug Sales, Revenue and Price Forecast (2018-2025)

11.1.1 EMEA Eosinophilic Esophagitis Drug Sales and Growth Rate Forecast (2018-2025)

11.1.2 EMEA Eosinophilic Esophagitis Drug Revenue and Growth Rate Forecast (2018-2025)

11.1.3 EMEA Eosinophilic Esophagitis Drug Price and Trend Forecast (2018-2025)

11.2 EMEA Eosinophilic Esophagitis Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)

11.3 Europe Eosinophilic Esophagitis Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)

11.4 Middle Eastt Eosinophilic Esophagitis Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)

11.5 Africa Eosinophilic Esophagitis Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)

11.6 EMEA Eosinophilic Esophagitis Drug Sales Forecast by Type (2018-2025)

11.7 EMEA Eosinophilic Esophagitis Drug Sales Forecast by Application (2018-2025)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Eosinophilic Esophagitis Drug

Figure EMEA Eosinophilic Esophagitis Drug Sales Volume (K Pcs) by Type (2013-2025)

Figure EMEA Eosinophilic Esophagitis Drug Sales Volume Market Share by Type (Product Category) in 2017

Figure RPC-4046 Product Picture

Figure Budesonide Product Picture

Figure Qi-201 Product Picture

Figure CALY-002 Product Picture

Figure Others Product Picture

Figure EMEA Eosinophilic Esophagitis Drug Sales Volume (K Pcs) by Application (2013-2025)

Figure EMEA Sales Market Share of Eosinophilic Esophagitis Drug by Application in 2017

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Others Examples

Table Key Downstream Customer in Others

Figure EMEA Eosinophilic Esophagitis Drug Market Size (Million USD) by Region (2013-2025)

Figure Europe Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure Europe Eosinophilic Esophagitis Drug Revenue (Million USD) Status and Forecast by Countries

Figure Middle East Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure Middle East Eosinophilic Esophagitis Drug Revenue (Million USD) Status and Forecast by Countries

Figure Africa Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure Africa Eosinophilic Esophagitis Drug Revenue (Million USD) Status and Forecast by Countries

Figure EMEA Eosinophilic Esophagitis Drug Sales Volume and Growth Rate (2013-2025)

Figure EMEA Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure EMEA Eosinophilic Esophagitis Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)

Table EMEA Eosinophilic Esophagitis Drug Sales Volume (K Pcs) of Major Players (2013-2018)

Table EMEA Eosinophilic Esophagitis Drug Sales Share by Players (2013-2018)

Figure 2017 Eosinophilic Esophagitis Drug Sales Share by Players

Figure 2017 Eosinophilic Esophagitis Drug Sales Share by Players

Figure EMEA Eosinophilic Esophagitis Drug Market Major Players Product Revenue (Million USD) (2013-2018)

Table EMEA Eosinophilic Esophagitis Drug Revenue (Million USD) by Players (2013-2018)

Table EMEA Eosinophilic Esophagitis Drug Revenue Share by Players (2013-2018)

Table 2017 EMEA Eosinophilic Esophagitis Drug Revenue Share by Players

Table 2017 EMEA Eosinophilic Esophagitis Drug Revenue Share by Players

Table EMEA Eosinophilic Esophagitis Drug Sale Price (USD/Pcs) by Players (2013-2018)

Table EMEA Eosinophilic Esophagitis Drug Sales (K Pcs) and Market Share by Type (2013-2018)

Table EMEA Eosinophilic Esophagitis Drug Sales Share by Type (2013-2018)

Figure Sales Market Share of Eosinophilic Esophagitis Drug by Type (2013-2018)

Figure EMEA Eosinophilic Esophagitis Drug Sales Market Share by Type (2013-2018)

Table EMEA Eosinophilic Esophagitis Drug Revenue (Million USD) and Market Share by Type (2013-2018)

Table EMEA Eosinophilic Esophagitis Drug Revenue Share by Type (2013-2018)

Figure Revenue Market Share of Eosinophilic Esophagitis Drug by Type in 2017

Table EMEA Eosinophilic Esophagitis Drug Sale Price (USD/Pcs) by Type (2013-2018)

Table EMEA Eosinophilic Esophagitis Drug Sales (K Pcs) and Market Share by Application (2013-2018)

Table EMEA Eosinophilic Esophagitis Drug Sales Share by Application (2013-2018)

Figure Sales Market Share of Eosinophilic Esophagitis Drug by Application (2013-2018)

Figure EMEA Eosinophilic Esophagitis Drug Sales Market Share by Application in 2017

Table EMEA Eosinophilic Esophagitis Drug Sales (K Pcs) and Market Share by Region (2013-2018)

Table EMEA Eosinophilic Esophagitis Drug Sales Share by Region (2013-2018)

Figure Sales Market Share of Eosinophilic Esophagitis Drug by Region (2013-2018)

Figure EMEA Eosinophilic Esophagitis Drug Sales Market Share in 2017

Table EMEA Eosinophilic Esophagitis Drug Revenue (Million USD) and Market Share by Region (2013-2018)

Table EMEA Eosinophilic Esophagitis Drug Revenue Share by Region (2013-2018)

Figure Revenue Market Share of Eosinophilic Esophagitis Drug by Region (2013-2018)

Figure EMEA Eosinophilic Esophagitis Drug Revenue Market Share Regions in 2017

Table EMEA Eosinophilic Esophagitis Drug Sales Price (USD/Pcs) by Region (2013-2018)

Figure Europe Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Europe Eosinophilic Esophagitis Drug Revenue and Growth Rate (2013-2018)

Table Europe Eosinophilic Esophagitis Drug Sales (K Pcs) by Type (2013-2018)

Table Europe Eosinophilic Esophagitis Drug Market Share by Type (2013-2018)

Figure Europe Eosinophilic Esophagitis Drug Market Share by Type in 2017

Table Europe Eosinophilic Esophagitis Drug Sales (K Pcs) by Application (2013-2018)

Table Europe Eosinophilic Esophagitis Drug Market Share by Application (2013-2018)

Figure Europe Eosinophilic Esophagitis Drug Market Share by Application in 2017

Table Europe Eosinophilic Esophagitis Drug Sales (K Pcs) by Countries (2013-2018)

Table Europe Eosinophilic Esophagitis Drug Sales Market Share by Countries (2013-2018)

Figure Europe Eosinophilic Esophagitis Drug Sales Market Share by Countries (2013-2018)

Figure Europe Eosinophilic Esophagitis Drug Sales Market Share by Countries in 2017

Table Europe Eosinophilic Esophagitis Drug Revenue (Million USD) by Countries (2013-2018)

Table Europe Eosinophilic Esophagitis Drug Revenue Market Share by Countries (2013-2018)

Figure Europe Eosinophilic Esophagitis Drug Revenue Market Share by Countries (2013-2018)

Figure Europe Eosinophilic Esophagitis Drug Revenue Market Share by Countries in 2017

Figure Germany Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure France Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure UK Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Russia Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Italy Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Benelux Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Middle East Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Middle East Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate (2013-2018)

Table Middle East Eosinophilic Esophagitis Drug Sales (K Pcs) by Type (2013-2018)

Table Middle East Eosinophilic Esophagitis Drug Market Share by Type (2013-2018)

Figure Middle East Eosinophilic Esophagitis Drug Market Share by Type (2013-2018)

Table Middle East Eosinophilic Esophagitis Drug Sales (K Pcs) by Applications (2013-2018)

Table Middle East Eosinophilic Esophagitis Drug Market Share by Applications (2013-2018)

Figure Middle East Eosinophilic Esophagitis Drug Sales Market Share by Application in 2017

Table Middle East Eosinophilic Esophagitis Drug Sales Volume (K Pcs) by Countries (2013-2018)

Table Middle East Eosinophilic Esophagitis Drug Sales Volume Market Share by Countries (2013-2018)

Figure Middle East Eosinophilic Esophagitis Drug Sales Volume Market Share by Countries in 2017

Table Middle East Eosinophilic Esophagitis Drug Revenue (Million USD) by Countries (2013-2018)

Table Middle East Eosinophilic Esophagitis Drug Revenue Market Share by Countries (2013-2018)

Figure Middle East Eosinophilic Esophagitis Drug Revenue Market Share by Countries (2013-2018)

Figure Middle East Eosinophilic Esophagitis Drug Revenue Market Share by Countries in 2017

Figure Saudi Arabia Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Israel Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure UAE Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Iran Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Africa Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Africa Eosinophilic Esophagitis Drug Revenue (Million USD) and Growth Rate (2013-2018)

Table Africa Eosinophilic Esophagitis Drug Sales (K Pcs) by Type (2013-2018)

Table Africa Eosinophilic Esophagitis Drug Sales Market Share by Type (2013-2018)

Figure Africa Eosinophilic Esophagitis Drug Sales Market Share by Type (2013-2018)

Figure Africa Eosinophilic Esophagitis Drug Sales Market Share by Type in 2017

Table Africa Eosinophilic Esophagitis Drug Sales (K Pcs) by Application (2013-2018)

Table Africa Eosinophilic Esophagitis Drug Sales Market Share by Application (2013-2018)

Figure Africa Eosinophilic Esophagitis Drug Sales Market Share by Application (2013-2018)

Table Africa Eosinophilic Esophagitis Drug Sales Volume (K Pcs) by Countries (2013-2018)

Table Africa Eosinophilic Esophagitis Drug Sales Market Share by Countries (2013-2018)

Figure Africa Eosinophilic Esophagitis Drug Sales Market Share by Countries (2013-2018)

Figure Africa Eosinophilic Esophagitis Drug Sales Market Share by Countries in 2017

Table Africa Eosinophilic Esophagitis Drug Revenue (Million USD) by Countries (2013-2018)

Table Africa Eosinophilic Esophagitis Drug Revenue Market Share by Countries (2013-2018)

Figure Africa Eosinophilic Esophagitis Drug Revenue Market Share by Countries (2013-2018)

Figure Africa Eosinophilic Esophagitis Drug Revenue Market Share by Countries in 2017

Figure South Africa Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Nigeria Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Egypt Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Algeria Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Table Adare Pharmaceuticals Inc Eosinophilic Esophagitis Drug Basic Information List

Table Adare Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Adare Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Adare Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales Market Share in EMEA (2013-2018)

Figure Adare Pharmaceuticals Inc Eosinophilic Esophagitis Drug Revenue Market Share in EMEA (2013-2018)

Table Calypso Biotech SA Eosinophilic Esophagitis Drug Basic Information List

Table Calypso Biotech SA Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Calypso Biotech SA Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Calypso Biotech SA Eosinophilic Esophagitis Drug Sales Market Share in EMEA (2013-2018)

Figure Calypso Biotech SA Eosinophilic Esophagitis Drug Revenue Market Share in EMEA (2013-2018)

Table Celgene Corp Eosinophilic Esophagitis Drug Basic Information List

Table Celgene Corp Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Celgene Corp Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Celgene Corp Eosinophilic Esophagitis Drug Sales Market Share in EMEA (2013-2018)

Figure Celgene Corp Eosinophilic Esophagitis Drug Revenue Market Share in EMEA (2013-2018)

Table DBV Technologies SA Eosinophilic Esophagitis Drug Basic Information List

Table DBV Technologies SA Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure DBV Technologies SA Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure DBV Technologies SA Eosinophilic Esophagitis Drug Sales Market Share in EMEA (2013-2018)

Figure DBV Technologies SA Eosinophilic Esophagitis Drug Revenue Market Share in EMEA (2013-2018)

Table Dr. Falk Pharma GmbH Eosinophilic Esophagitis Drug Basic Information List

Table Dr. Falk Pharma GmbH Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Dr. Falk Pharma GmbH Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Dr. Falk Pharma GmbH Eosinophilic Esophagitis Drug Sales Market Share in EMEA (2013-2018)

Figure Dr. Falk Pharma GmbH Eosinophilic Esophagitis Drug Revenue Market Share in EMEA (2013-2018)

Table Quorum Innovations LLC Eosinophilic Esophagitis Drug Basic Information List

Table Quorum Innovations LLC Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Quorum Innovations LLC Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Quorum Innovations LLC Eosinophilic Esophagitis Drug Sales Market Share in EMEA (2013-2018)

Figure Quorum Innovations LLC Eosinophilic Esophagitis Drug Revenue Market Share in EMEA (2013-2018)

Table Regeneron Pharmaceuticals Inc Eosinophilic Esophagitis Drug Basic Information List

Table Regeneron Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Regeneron Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Regeneron Pharmaceuticals Inc Eosinophilic Esophagitis Drug Sales Market Share in EMEA (2013-2018)

Figure Regeneron Pharmaceuticals Inc Eosinophilic Esophagitis Drug Revenue Market Share in EMEA (2013-2018)

Table Shire Plc Eosinophilic Esophagitis Drug Basic Information List

Table Shire Plc Eosinophilic Esophagitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Shire Plc Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate (2013-2018)

Figure Shire Plc Eosinophilic Esophagitis Drug Sales Market Share in EMEA (2013-2018)

Figure Shire Plc Eosinophilic Esophagitis Drug Revenue Market Share in EMEA (2013-2018)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Eosinophilic Esophagitis Drug

Figure Manufacturing Process Analysis of Eosinophilic Esophagitis Drug

Figure Eosinophilic Esophagitis Drug Industrial Chain Analysis

Table Raw Materials Sources of Eosinophilic Esophagitis Drug Major Manufacturers in 2017

Table Major Buyers of Eosinophilic Esophagitis Drug

Table Distributors/Traders List

Figure EMEA Eosinophilic Esophagitis Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)

Figure EMEA Eosinophilic Esophagitis Drug Revenue and Growth Rate Forecast (2018-2025)

Figure EMEA Eosinophilic Esophagitis Drug Price (USD/Pcs) and Trend Forecast (2018-2025)

Table EMEA Eosinophilic Esophagitis Drug Sales (K Pcs) Forecast by Region (2018-2025)

Figure EMEA Eosinophilic Esophagitis Drug Sales Market Share Forecast by Region (2018-2025)

Table EMEA Eosinophilic Esophagitis Drug Revenue (Million USD) Forecast by Region (2018-2025)

Figure EMEA Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Region (2018-2025)

Table Europe Eosinophilic Esophagitis Drug Sales (K Pcs) Forecast by Countries (2018-2025)

Figure Europe Eosinophilic Esophagitis Drug Sales Market Share Forecast by Countries (2018-2025)

Table Europe Eosinophilic Esophagitis Drug Revenue (Million USD) Forecast by Countries (2018-2025)

Figure Europe Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Countries (2018-2025)

Table Middle East Eosinophilic Esophagitis Drug Sales (K Pcs) Forecast by Countries (2018-2025)

Figure Middle East Eosinophilic Esophagitis Drug Sales Market Share Forecast by Countries (2018-2025)

Table Middle East Eosinophilic Esophagitis Drug Revenue (Million USD) Forecast by Countries (2018-2025)

Figure Middle East Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Countries (2018-2025)

Table Africa Eosinophilic Esophagitis Drug Sales (K Pcs) Forecast by Countries (2018-2025)

Figure Africa Eosinophilic Esophagitis Drug Sales Market Share Forecast by Countries (2018-2025)

Table Africa Eosinophilic Esophagitis Drug Revenue (Million USD) Forecast by Countries (2018-2025)

Figure Africa Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Countries (2018-2025)

Table EMEA Eosinophilic Esophagitis Drug Sales (K Pcs) Forecast by Type (2018-2025)

Figure EMEA Eosinophilic Esophagitis Drug Sales Market Share Forecast by Type (2018-2025)

Table EMEA Eosinophilic Esophagitis Drug Sales (K Pcs) Forecast by Application (2018-2025)

Figure EMEA Eosinophilic Esophagitis Drug Sales Market Share Forecast by Application (2018-2025)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources